Amoxicillin Drug Market to Rise at CAGR of 4% to Reach US$ 6.64 Billion by 2034: Fact.MR Study

The global amoxicillin drug market is now worth US$ 4.48 billion in 2024 and is anticipated to grow at a CAGR of 4% to reach US$ 6.64 billion by 2034.

Amoxicillin falls under commonly prescribed antibiotics worldwide. From some 2023 reports, it was found that approximately 18.26% of all antibiotic outpatient prescriptions were for amoxicillin with virtually 270 million total antibiotic prescriptions, this represents virtually 49 million amoxicillin prescriptions in the United States alone. This consumption is also expected to continue on the rise globally with different volumes by region.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3186

It is the most common antibiotic in Europe, Asia Pacific, and America, used mostly for bacterial infections, including respiratory tract infections, otitis media, and skin infections.

Amoxicillin drugs is one of the generic drugs of the Amoxil branded drug and is widely employed in the cure of bacterial infections. The amoxicillin drugs belong to the class of drug β-lactam antibiotics. The rising occurrence of bacterial infections globally, particularly, in low-income and developing nations is one of the motives behind the amoxicillin drug demand increase and thereby stimulating the growth of the amoxicillin drug market.

In the 1980s, the Food and Drug Administration (FDA) initially approved amoxicillin drug.

The surveillance published by the World Health Organization (WHO) indicated that in high- and low-income nations rising rates of antibiotic resistance to a number of serious bacterial infections. The Global Antimicrobial Surveillance System (GLASS) revealed the prevalence of widespread antibiotic resistance among 500,000 individuals with a high risk of bacterial infections in 22 nations.

Market Dynamics

Nowadays, various branded and generic forms of amoxicillin drugs are found in the market. Various drug companies are producing amoxicillin drugs and supplying them in the market.

The amoxicillin drugs are also used in combination with other drugs for the treatment of a bacterial infection, e.g., triple therapy (amoxicillin/clarithromycin/lansoprazole) and dual therapy (amoxicillin/lansoprazole). The dual and triple therapies are under investigation.

The increasing number of clinical trials to verify the effectiveness and impact of combination drugs with amoxicillin drugs is likely to propel the growth of the amoxicillin drug market during the forecast period. Nevertheless, the most frequent side effects reported in clinical trials of combination drugs are diarrhea, vomiting, rash, and nausea.

This postpones the introduction of combination drugs in the market and obstructs the growth of the amoxicillin drug market during the forecast period.

Browse Full Report: https://www.factmr.com/report/3186/amoxicillin-drugs-market

Region-wise Outlook

The North American region is anticipated to reflect the maximum revenue growth owing to extensive investment in clinical trials and R&D expenditures, followed by Europe. The Asia-Pacific amoxicillin drug market is anticipated to reflect strong CAGR growth owing to a huge patient base who are highly prone to bacterial infections due to poor sanitation, contaminated drinking water, and dense population.

Latin America and Middle East & Africa are also highly prone to bacterial infections because of the lack of safe water.

Key Players

Some of the prominent players that exist in the international amoxicillin drug market are JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP., Sanis Health Inc., Nucare Pharmaceuticals, Inc., Northwind Pharmaceuticals, A-S Medication Solutions, Bryant ranch prepack and others.

Segmentation of Amoxicillin Drug Market Research

By Infection Type :
Skin Infection
ENT
Stomach Infection
Lungs Infection
Urinary Tract Infection
Pneumonia
Bronchitis
Gonorrhea
By Route of Administration :
Oral
Intravenous
By Form :
Tablets
Capsules
Suspensions
Syrups
Powder
By Distribution Channel :
Hospitals Pharmacies
Drug Stores
Retail Stores
Online Pharmacies
By Region :
North America
Western Europe
Eastern Europe
Latin America
East Asia
South Asia & Pacific
Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Cerebral Angiography Market
https://www.factmr.com/report/cerebral-angiography-market
Behavioural Health Treatment Market
https://www.factmr.com/report/4370/behavioural-health-treatment-market
Sterility Indicators Market
https://www.factmr.com/report/sterility-indicators-market
qPCR Reagents Market
https://www.factmr.com/report/qpcr-reagents-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.